A woman with acute intermittent porphyria (AIP) developed acute liver injury due to treatment with Givlaari (givosiran), according…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The case of a teenager in Nepal who was diagnosed with porphyria following a detailed series of clinical tests…
The case of a woman with porphyria, who had a dangerous blood clot develop in a large vein heading…
A new mutation in the HMBS gene was found to be the cause of acute intermittent porphyria (AIP) in…
A wearable device capable of measuring light exposure could help to predict symptoms of erythropoietic protoporphyria (EPP), and may…
The case of a woman with variegate porphyria (VP) diagnosed following an acute attack that occurred after weight loss…
Porphyria cutanea tarda (PCT), the most common form of porphyria, is much less common among people with kidney disease…
People with acute intermittent porphyria (AIP) who have health problems related to the kidneys or liver are more likely…
A 26-year-old woman with acute intermittent porphyria (AIP) was successfully treated with hemin and is recovering, despite delays due…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…